Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001882909-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
52,477
Total Value
$1,147,397.89
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 2,500 | $22.40 | $56,000.00 | 51,580 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 6,250 | $8.93 | $55,812.50 | 57,830 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 6,500 | $20.46 | $132,990.00 | 64,330 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Apr 14, 2026 | Sale | 21,977 | $41.07 | $902,595.39 | 42,353 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Employee stock option (right to buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 5,000 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Employee stock option (right to buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 6,250 | $0.00 | $0.00 | 12,500 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Employee stock option (right to buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 6,500 | $0.00 | $0.00 | 19,500 | Direct | โ | View Details |